Pharmacokinetic equivalence of CT‐P39 and reference omalizumab in healthy individuals: A randomised, double‐blind, parallel‐group, Phase 1 trial

por Maurer, Marcus, Saini, Sarbjit S., McLendon, Kristi, Wabnitz, Paul, Kim, Sunghyun, Ahn, Keumyoung, Kim, Suyoung, Lee, Sewon, Grattan, Clive
Publicado 2022

Candidate Bevacizumab Biosimilar CT-P16 versus European Union Reference Bevacizumab in Patients with Metastatic or Recurrent Non-Small Cell Lung Cancer: A Randomized Controlled Tri...

por Verschraegen, Claire, Andric, Zoran, Moiseenko, Fedor, Makharadze, Tamta, Shevnya, Sergii, Oleksiienko, Alona, Yañez Ruiz, Eduardo, Kim, SungHyun, Ahn, KeumYoung, Park, TaeHong, Park, Sijin, Ju, Hana, Ohe, Yuichiro
Publicado 2022

Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Co...

por Stebbing, Justin, Baranau, Yauheni, Baryash, Valery, Moiseyenko, Vladimir, Boliukh, Dmytro, Antone, Nicoleta, Manikhas, Alexey, Chornobai, Anatolii, Park, Taehong, Baek, Eric Hyungseok, Lee, Jaeyong, Choi, Jiin, Kim, Nahyun, Ahn, Keumyoung, Lee, Sang Joon, Kim, Sunghyun
Publicado 2023

Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea

por Lee, Ji Yeon, Bu, Seon Hee, Song, EunHyang, Cho, Seongcheol, Yu, Sungbong, Kim, Jungok, Kym, Sungmin, Seo, Kwang Won, Kwon, Ki Tae, Kim, Jin Yong, Kim, Sunghyun, Ahn, Keumyoung, Jung, Nahyun, Lee, Yeonmi, Jung, Yoobin, Hwang, Chankyoung, Park, Sang Won
Publicado 2023

Preclinical assessment and randomized Phase I study of CT-P63, a broadly neutralizing antibody targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

por Seo, Ji-Min, Kang, Bobin, Song, Rina, Noh, Hanmi, Kim, Cheolmin, Kim, Jong-In, Kim, Minsoo, Ryu, Dong-Kyun, Lee, Min-Ho, Yang, Jeong-Sun, Kim, Kyung-Chang, Lee, Joo-Yeon, Lee, Hansaem, Woo, Hye-Min, Kim, Jun-Won, Choi, Jung-Ah, Song, Manki, Tomaszewska-Kiecana, Monika, Wołowik, Anna, Kulesza, Agnieszka, Kim, Sunghyun, Ahn, Keumyoung, Jung, Nahyun, Lee, Soo-Young
Publicado 2022